Altair Nanotechnologies Inc. ALTI 深 沪
等待开盘 11-04 09:30:00 美东时间
3.95
+0.010
+0.25%
华盛通- 最 高3.99
- 今 开3.95
- 成交量 8.14万股
- 最 低 3.81
- 昨 收 3.94
- 总市值 4.03亿
- 52周最高 4.93
- 市盈率 静 --
- 换手率 0.08%
- 52周最低 2.33
- 委 比 23.08%
- 总股本 1.02亿
- 历史最高 27.50
- 量 比 0.95
- 振 幅 4.57%
- 历史最低 2.33
- 每 手 1
- 风险率 0.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Bloomberg Adds Hamilton Lane Private Market Indices to the Bloomberg Terminal
Leading global private markets firm Hamilton Lane launches private markets indices on Bloomberg, providing investors robust benchmarking for private equity, credit, and real assets fund perf...
10-29 19:00
Sandstorm Gold Royalties Receives Court Approval for Arrangement with Royal Gold
VANCOUVER, BC, Oct. 15, 2025 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) is pleased to announce that the Supreme Cou...
10-16 04:15
REGENXBIO to Present Data on Sura-vec for Diabetic Retinopathy at American Academy of Ophthalmology
REGENXBIO Inc. (NASDAQ:RGNX) today announced that it will present interim data from the Phase II ALTITUDE® trial evaluating suprachoroidal delivery of surabgene lomparvovec (ABBV-RGX-314, sura-vec) for the treatment
10-09 19:25
Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
Altimmune appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer, succeeding Scott Harris, MD, who will remain as a Senior Strategic Advisor until February 2026. Arbet-Engels brings over 30 years of experience in clinical development, regulatory approvals, and commercial launches, and will lead the Phase 3 trial of pemvidutide for metabolic dysfunction-associated steatohepatitis (MASH) and other indications. His appointment reflects ...
09-29 11:30
Sandstorm Gold Royalties Declares Quarterly Dividend
VANCOUVER, BC, Sept. 15, 2025 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) is pleased to announce that its Board of D...
09-16 04:15
Earnings Scheduled For August 11, 2025
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to rep...
08-11 16:32
AlTi Global's Earnings Outlook
AlTi Global (NASDAQ:ALTI) is preparing to release its quarterly earnings on Mon...
08-09 01:11
ALTi Global gains on report of take-private talks
ALTi Global (NASDAQ:ALTI) jumped 17% on a report that the wealth management firm is pursuing a take private. The wealth manager hired JPMorgan to serve as its advisor, according to a report from Cityw...
08-06 04:23
Watching AlTi Global; Shares See Volume To The Upside, Traders Circulate Citywire Article Saying "$76B AlTi Global pursuing take-private sale: Sources"
https://citywire.com/pro-buyer/news/76bn-alti-global-pursuing-take-private-sale-sources/a2471556
08-06 03:51
Sandstorm Gold Royalties Supports Royal Gold's Acquisition of Kansanshi Gold Stream
VANCOUVER, BC, Aug. 5, 2025 /PRNewswire/ - Sandstorm Gold Ltd. ("Sandstorm Gold Royalties", "Sandstorm" or the "Company") (NYSE: SAND) (TSX: SSL) today acknowledges and supports Royal Gold I...
08-05 15:10
